These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 15895401)

  • 1. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
    Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.
    Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures.
    Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R
    Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
    Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
    Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of non-alcoholic fatty liver disease.
    Bellentani S; Scaglioni F; Marino M; Bedogni G
    Dig Dis; 2010; 28(1):155-61. PubMed ID: 20460905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy.
    Shieh K; Gilchrist JM; Promrat K
    Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    Graham RC; Burke A; Stettler N
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
    Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
    Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The epidemiology of nonalcoholic fatty liver disease in adults.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.
    Mohan V; Farooq S; Deepa M; Ravikumar R; Pitchumoni CS
    Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.